Key statistics
On Tuesday, Immunitybio Inc (26CA:BER) closed at 4.74, 65.84% above the 52 week low of 2.86 set on Dec 12, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.11 |
---|---|
High | 5.22 |
Low | 4.74 |
Bid | 4.61 |
Offer | 4.76 |
Previous close | 5.11 |
Average volume | 6.49k |
---|---|
Shares outstanding | 696.53m |
Free float | 159.61m |
P/E (TTM) | -- |
Market cap | 3.80bn USD |
EPS (TTM) | -0.9356 USD |
Data delayed at least 15 minutes, as of Nov 12 2024 20:40 GMT.
More ▼
Press releases
- ImmunityBio Reports Third-Quarter 2024 Financial Results
- First Patients Dosed in Phase 1 Clinical Study of ImmunityBio’s CAR-NK Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma
- ImmunityBio to Participate in the Jefferies London Healthcare Conference
- ImmunityBio Presents Positive Long-Term Overall Survival Data in Non-Small Cell Lung Cancer Patients and Announces Registrational Intent Phase 3 Trials with ANKTIVA® and Checkpoint Immunotherapy at World Conference on Lung Cancer